Alira Health's Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful Market Access.
WHAT WE DO
We optimize pricing strategies.
We map reimbursement pathways.
We enable value communication to key stakeholders.
KEY ELEMENTS OF MARKET ACCESS
Enable 3P Collaboration
Achieve greater acceptance by Payers, Physicians, and Patients
Determine, demonstrate and communicate the benefits of a drug
Provide the information decision-makers need for listing, pricing and reimbursement
Optimize pricing strategy to balance needs of stakeholders and patients
MARKET ACCESS EXPERTISE
Alira Health’s proven capabilities provide a powerful advantage in delivering successful market access advisory.
Our rigorous market research methods turn raw epidemiology data into useful insights to quantify a drug’s market potential.
Our techniques measure the value for money of treatment subject to constraints such as clinical setting, geography in scope, and target patients, among others.
Our process results in maximizing the potential commercial value of a drug by prioritizing opportunities based on market, geography, settings, barriers to entry, and competition avoidance options.
Our work distills the key benefits of a drug to payers (public/private, local/national insurance), buyers (prescribers) and consumers (target patients).
Want to learn more about our Market Access work? Contact William Hariri